Plus Therapeutics, Inc.
PSTV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7,636 | $5,497 | $8,402 | $12,675 |
| - Cash | $76 | $8,554 | $18,120 | $18,400 |
| + Debt | $3,367 | $4,181 | $5,645 | $6,993 |
| Enterprise Value | $10,927 | $1,124 | -$4,073 | $1,268 |
| Revenue | $5,824 | $4,913 | $224 | $0 |
| % Growth | 18.5% | 2,093.3% | – | – |
| Gross Profit | $4,972 | -$4,777 | -$488 | -$66 |
| % Margin | 85.4% | -97.2% | -217.9% | – |
| EBITDA | -$8,402 | -$12,693 | -$18,852 | -$12,048 |
| % Margin | -144.3% | -258.4% | -8,416.1% | – |
| Net Income | -$12,978 | -$13,316 | -$20,275 | -$13,399 |
| % Margin | -222.8% | -271% | -9,051.3% | – |
| EPS Diluted | -2.34 | -4.24 | -11.55 | -17.78 |
| % Growth | 44.8% | 63.3% | 35% | – |
| Operating Cash Flow | -$10,554 | -$12,851 | -$12,972 | -$10,280 |
| Capital Expenditures | -$146 | -$160 | -$759 | -$144 |
| Free Cash Flow | -$10,700 | -$13,011 | -$13,731 | -$10,424 |